PD Dr. oec. troph. Sabrina Schlesinger

Selected Publications

• Wolf K, Bongaerts BWC, Schneider A, Huth C, Meisinger C, Peters A, Schneider A, Wittsiepe J, Schramm K-W, Greiser KH, Hartwig S, Kluttig A, Rathmann W 2019. Persistent organic pollutants and the incidence of type 2 diabetes in the CARLA and KORA cohort studies. Environ Res. 129: 221-228. https://doi.org/10.1016/j.envint.2019.05.030
• Kowall B, Rathmann W, Bongaerts B, Kuss O, Stang A, Roden M, Herder C, Koenig W, Huth C, Heier M, Thorand B, Ladwig K-H, Holle R, Meisinger C, Peters A 2019. Incidence Rates of Type 2 Diabetes in People With Impaired Fasting Glucose (ADA vs. WHO Criteria) and Impaired Glucose Tolerance: Results From an Older Population (KORA S4/F4/FF4 Study). Diabetes Care. 42: e18-e20. https://doi.org/10.2337/dc18-1473
• Rathmann W, Strassburger K, Bongaerts B, Kuss O, Müssig K, Burkart V, Szendroedi J, Kotzka J, Knebel B, Al-Hasani H, Roden M for the GDS Group 2019. A variant of the glucose transporter gene SLC2A2 modifies the glycaemic response to metformin therapy in recently diagnosed type 2 diabetes. Diabetologia. 62: 286-291. https://doi.org/10.1007/s00125-018-4759-z
• Rathmann W, Strassburger K, Bongaerts B, Bobrov P, Kuss O, Müssig K, Markgraf D, Szendroedi J, Herder C, Roden M for the GDS Group 2017. Impact of Insulin Sensitivity, Beta-cell Function and Glycemic Control on Initiation of Second-Line Glucose-Lowering Treatment in Newly Diagnosed Type 2 Diabetes. Diabetes Obes Metab. 19: 866-873. https://doi.org/10.1111/dom.12894
• Jacobs E, Hoyer A, Brinks R, Icks A, Kuss O, Rathmann W 2017. Healthcare costs of Type 2 diabetes in Germany. Diabet Med. 34: 855-861. https://doi.org/10.1111/dme.13336
• Jacobs E, Hoyer A, Brinks R, Kuss O, Rathmann W 2017. Burden of Mortality Attributable to Diagnosed Diabetes: A Nationwide Analysis Based on Claims Data from 65 Million People in Germany. Diabetes Care. 40: 1703-1709. https://doi.org/10.2337/dc17-0954
• Tamayo T, Brinks R, Hoyer A, Kuss O, Rathmann W 2016. The Prevalence and Incidence of Diabetes in Germany. Dtsch Arztebl Int. 113: 177-82. https://doi.org/10.3238/arztebl.2016.0177
• Kowall B, Rathmann W, Kostev K 2015. Are sulfonylurea and insulin therapies associated with a larger risk of cancer than metformin therapy? A retrospective database analysis. Diabetes Care. 38: 59-65. https://doi.org/10.2337/dc14-0977
• Tamayo T, Rosenbauer J, Wild SH, Spijkerman AMW, Baan C, Forouhi NG, Herder C, Rathmann W 2014. Diabetes in Europe: an update. Diabetes Res Clin Pract. 103: 206-17. https://doi.org/10.1016/j.diabres.2013.11.007